Australia's CSL Slapped With U.S. FDA Warning Letter Over Flu Vaccine

U.S. FDA's Center for Biologics Evaluation and Research slapped CSL Biotherapies with a warning letter June 15 for significant objectionable conditions related to current good manufacturing practices at its Victoria, Australia, manufacturing plant